• Activity INFORMATION

  Overview

  In a podcast style discussion, Mike Corvino, PharmD and Cole Swanson, PharmD examine injectable medications used to treat type II diabetes and their effect on diabetes management.  Over the last decade, multiple GLP-1 receptor agonists have come to market and have changed many clinicians approach to pharmacotherapy in type II diabetes.  Pharmacists and nurses frequently encounter patients who are using injectables for diabetes management. It is important that pharmacists and nurses understand the appropriate use of these medications and know how to identify patients who could benefit from them.  This session seeks to explore these topics, focusing on how this information can best be incorporated into daily medical practice.  

  Access the original podcast here.

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize the place in therapy for injectable medications for the management of type II diabetes.

  Identify durations of action for different insulins and when to use them.

  Identify appropriate dosing strategies for basal and prandial insulin regimens.

  Recognize landmark clinical trials relating to GLP-1 receptor agonists to compare the therapeutic differences.

  Identify available injectable insulins and GLP-1 receptor agonists.

  Nurse

  Identify available injectable insulins and GLP-1 receptor agonists.

  Recognize the place in therapy for injectable medications for the management of type II diabetes.

  Identify appropriate dosing strategies for basal and prandial insulin regimens.

  Identify durations of action for different insulins and when to use them.

  Recognize landmark clinical trials relating to GLP-1 receptor agonists to compare the therapeutic differences.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-863886

  Universal Activity Number

  Pharmacist 0798-0000-21-146-H01-P
  Nurse 0798-0000-21-146-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).